HotSpot Therapeutics, Inc.

📍 Boston, United States🗓 Founded 2017👥 76 employees💰 Last funded Oct 2022
Biotechnology Research🌐 hotspotthera.com
Website LinkedIn
Inspired by nature’s ability to regulate protein function to restore health, HotSpot Therapeutics is discovering new allosteric therapies with the ability to treat disease in new ways. Unlike conventional drug discovery, which focuses on targeting the active sites of proteins, HotSpot has developed a technology platform to uncover nature’s privileged regulatory hotspots – pockets remote from the active site that are critical to protein function. Our team is designing novel therapies directed at regulatory hotspots, allowing us to treat diseases with limited or no known treatment options. Hotspot medicines are superior to conventional therapeutics given their exquisite selectivity, potent in vivo pharmacology and attractive drug-like properties.
3
Total investors
0
Early stage
3
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Germany
1
Investor activity2021–2022 · investors recorded per year
2021120222
Recent (last 2y)Earlier
Frequently asked questions
Who invested in HotSpot Therapeutics, Inc.?
HotSpot Therapeutics, Inc. has 3 investors on record on gritt.io, 3 mid-stage.
When did HotSpot Therapeutics, Inc. last raise funding?
The most recent investment in HotSpot Therapeutics, Inc. recorded on gritt.io was in October 2022.
When was HotSpot Therapeutics, Inc. founded?
HotSpot Therapeutics, Inc. was founded in 2017.
What industry is HotSpot Therapeutics, Inc. in?
HotSpot Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is HotSpot Therapeutics, Inc. based?
HotSpot Therapeutics, Inc. is headquartered in Boston, United States.